FDA Approves First Systemic Treatment Olumiant (Baricitinib) for Alopecia Areata
Summary : The U.S. Food and Drug Administration approved Olumiant (baricitinib) oral tablets to treat adult patients with severe alopecia areata, a…
Summary : The U.S. Food and Drug Administration approved Olumiant (baricitinib) oral tablets to treat adult patients with severe alopecia areata, a…
Synopsis: The U.S. Food and Drug Administration has approved Agios Pharmaceuticals’ candidate treatment for a rare type of hemolytic anemia. The regulator…